(spp according to local resistance patterns), while ESCMID considers echinocandins as the preferred initial choice. areas, although a relative increase in the incidence of healthcare-associated BSI due FLAG tag Peptide to gram negatives has also been signaled in recent years, both in United States and FLAG tag Peptide in Europe.15-19 In addition, two recent studies have reported an equal prevalence of gram-positive and gram-negative bacteria as a cause of BSI in medical wards.7,13 In the first of these studies, an equal prevalence of gram-positive and gram-negative organisms was observed among 64 patients with BSI mainly hospitalized in medical wards.7 These results are consistent with those of a Spanish study on 702 patients with BSI, which reported a high prevalence of gram negatives in wards other than ICU.13 Although the small sample size of these studies does not allow any definite conclusion, such findings – if reproduced in larger FLAG tag Peptide surveys – might be of particular concern in those countries endemic for multidrug resistant (MDR) gram negatives. Indeed, these organisms are frequently resistant to most antibacterials available in the present time.20-22 In particular, extended spectrum -lactamase (ESBL)-producing Enterobacteriaceae, which are able to inactivate third generation cephalosporins, have rapidly spread around the world during the last 15?years, both because of the dissemination of successful clones and because of the ease of inter-bacterial transferability of resistance through plasmid-encoded enzymes.22-26 Similar mechanisms underlie the growing diffusion of carbapenemase-producing Enterobacteriaceae (CPE), CCNE1 which might dramatically threaten the effective treatment of healthcare-associated infections in the 21st century.20,21,27 Although these carbapenem-resistant organisms are currently endemic only in a few countries, FLAG tag Peptide mostly in Southern Europe, their diffusion is increasingly reported worldwide.28-30 With regard to IMW, Corcione et?al. recently observed that carbapenemase-producing (CPKP) was responsible for BSI at the same rate in medical wards and in ICU in a multicenter survey in North-West Italy.31 Consistently with these findings, we recently provided observational data suggesting a worrisome diffusion of CPKP in clinical wards (mainly medical) which were not considered at risk for CPKP spread, raising concern as to whether current infection-control efforts are sufficient to counteract CPKP diffusion, at least in some endemic hospitals.32,33 Besides bacteria, fungi, namely spp., are another important cause of healthcare-associated BSI both in United States and in Europe.34-37 The number of IMW patients with BSI due to these yeasts has considerably increased during the last decades.5,34,38 In a recent combined Italian and Spanish survey, 448 out of 995 patients with BSI due to spp were hospitalized in medical wards (46%).34 An even more impressive rate was reported in another Italian study focused on elderly patients, with as many as 98/145 episodes occurring in medical departments (67.6%).39 Although this trend toward a higher incidence of spp. infections in medical wards has not been confirmed so far in other countries,40,41 a global increase in the incidence of fungal BSI in IMW is expected in the near future, due to the increasing size of the population at risk. Indeed, several risk factors for invasive fungal diseases such as increasing age, immunosuppression, solid tumors, and indwelling devices are becoming increasingly common in IMW.39,42-45 Worth of note is the fact that epidemiological surveys such as those cited above usually rely on culture-proven episodes (i.e., bacteremia or candidemia), thus including only patients with blood cultures positive for the causative agent of BSI. The obvious benefit of this approach is the exclusion from the analyses of patients with non-infection-related SIRS. However, considering that the frequent atypical clinical presentation of BSI in IMW patients (see below) might not be consistent with the classical indications for collecting blood cultures,46 the real burden of BSI in IMW may be considerably underestimated. Risk factors In IMW patients, some common comorbidities and their complications predispose to BSI. Several leukocytes defects capable of impairing host defenses have been described in patients with FLAG tag Peptide diabetes mellitus.47-49 Bedridden patients with diabetes mellitus and peripheral vascular insufficiency are also at high risk for the development of cutaneous ulcers, with subsequent superimposed infections by gram-positive and gram-negative bacteria.47,49-52 Another example.